Cargando…
Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization
Background and Aims: The Albumin-Bilirubin (ALBI) grade is a good index for liver function evaluation and is also associated with the outcomes of hepatocellular carcinoma patients receiving TACE. However, the correlation between the dynamic change to the ALBI score and clinical outcome is seldom dis...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947376/ https://www.ncbi.nlm.nih.gov/pubmed/35328217 http://dx.doi.org/10.3390/diagnostics12030665 |
_version_ | 1784674424571559936 |
---|---|
author | Lin, Po-Ting Teng, Wei Jeng, Wen-Juei Chen, Wei-Ting Hsieh, Yi-Chung Huang, Chien-Hao Lui, Kar-Wai Hung, Chen-Fu Wang, Ching-Ting Chai, Pei-Mei Lin, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Sheen, I-Shyan |
author_facet | Lin, Po-Ting Teng, Wei Jeng, Wen-Juei Chen, Wei-Ting Hsieh, Yi-Chung Huang, Chien-Hao Lui, Kar-Wai Hung, Chen-Fu Wang, Ching-Ting Chai, Pei-Mei Lin, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Sheen, I-Shyan |
author_sort | Lin, Po-Ting |
collection | PubMed |
description | Background and Aims: The Albumin-Bilirubin (ALBI) grade is a good index for liver function evaluation and is also associated with the outcomes of hepatocellular carcinoma patients receiving TACE. However, the correlation between the dynamic change to the ALBI score and clinical outcome is seldom discussed. Therefore, this study aimed to investigate the application of ALBI grade and dynamic change of ALBI grade (delta ALBI grade) after first TACE for prognosis prediction in HCC patients with chronic hepatitis C infection. Method: From January 2005 to December 2015, newly diagnosed naive chronic hepatitis C-hepatocellular carcinoma (CHC-HCC) patients who were treated with TACE as the initial treatment at the Chang Gung Memorial Hospital, Linkou Medical Center, were retrospectively recruited. The pre-treatment host factors, tumor status and noninvasive markers were collected. The Cox regression model was used to identify independent predictors of overall survival and tumor recurrence. Results: Among 613 treatment-naive CHC-HCC patients, 430 patients died after repeated TACE during a median follow-up of 26.9 months. Complete remission after repeated TACE occurred in 46.2% patients, and 208 patients (33.9%) had tumor recurrence, with a median recurrence-free interval of 8.5 months. In Cox regression analysis, ALBI grade II/III (aHR: 1.088, p = 0.035) and increased delta ALBI grade (aHR: 1.456, p = 0.029) were independent predictive factors for tumor recurrence. Furthermore, ALBI grade II/III (aHR: 1.451, p = 0.005) and increased delta ALBI grade during treatment (aHR: 1.436, p = 0.006) were predictive factors for mortality, while achieving complete response after repeated TACE (aHR: 0.373, p < 0.001) and anti-viral therapy (aHR: 0.580, p = 0.002) were protective factors for mortality. Conclusion: Both ALBI and delta ALBI grade are independent parameters to predict survival and tumor recurrence of CHC-HCC patients receiving TACE treatment. |
format | Online Article Text |
id | pubmed-8947376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89473762022-03-25 Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization Lin, Po-Ting Teng, Wei Jeng, Wen-Juei Chen, Wei-Ting Hsieh, Yi-Chung Huang, Chien-Hao Lui, Kar-Wai Hung, Chen-Fu Wang, Ching-Ting Chai, Pei-Mei Lin, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Sheen, I-Shyan Diagnostics (Basel) Article Background and Aims: The Albumin-Bilirubin (ALBI) grade is a good index for liver function evaluation and is also associated with the outcomes of hepatocellular carcinoma patients receiving TACE. However, the correlation between the dynamic change to the ALBI score and clinical outcome is seldom discussed. Therefore, this study aimed to investigate the application of ALBI grade and dynamic change of ALBI grade (delta ALBI grade) after first TACE for prognosis prediction in HCC patients with chronic hepatitis C infection. Method: From January 2005 to December 2015, newly diagnosed naive chronic hepatitis C-hepatocellular carcinoma (CHC-HCC) patients who were treated with TACE as the initial treatment at the Chang Gung Memorial Hospital, Linkou Medical Center, were retrospectively recruited. The pre-treatment host factors, tumor status and noninvasive markers were collected. The Cox regression model was used to identify independent predictors of overall survival and tumor recurrence. Results: Among 613 treatment-naive CHC-HCC patients, 430 patients died after repeated TACE during a median follow-up of 26.9 months. Complete remission after repeated TACE occurred in 46.2% patients, and 208 patients (33.9%) had tumor recurrence, with a median recurrence-free interval of 8.5 months. In Cox regression analysis, ALBI grade II/III (aHR: 1.088, p = 0.035) and increased delta ALBI grade (aHR: 1.456, p = 0.029) were independent predictive factors for tumor recurrence. Furthermore, ALBI grade II/III (aHR: 1.451, p = 0.005) and increased delta ALBI grade during treatment (aHR: 1.436, p = 0.006) were predictive factors for mortality, while achieving complete response after repeated TACE (aHR: 0.373, p < 0.001) and anti-viral therapy (aHR: 0.580, p = 0.002) were protective factors for mortality. Conclusion: Both ALBI and delta ALBI grade are independent parameters to predict survival and tumor recurrence of CHC-HCC patients receiving TACE treatment. MDPI 2022-03-09 /pmc/articles/PMC8947376/ /pubmed/35328217 http://dx.doi.org/10.3390/diagnostics12030665 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lin, Po-Ting Teng, Wei Jeng, Wen-Juei Chen, Wei-Ting Hsieh, Yi-Chung Huang, Chien-Hao Lui, Kar-Wai Hung, Chen-Fu Wang, Ching-Ting Chai, Pei-Mei Lin, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Sheen, I-Shyan Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization |
title | Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization |
title_full | Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization |
title_fullStr | Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization |
title_full_unstemmed | Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization |
title_short | Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization |
title_sort | dynamic change of albumin-bilirubin score is good predictive parameter for prognosis in chronic hepatitis c-hepatocellular carcinoma patients receiving transarterial chemoembolization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947376/ https://www.ncbi.nlm.nih.gov/pubmed/35328217 http://dx.doi.org/10.3390/diagnostics12030665 |
work_keys_str_mv | AT linpoting dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT tengwei dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT jengwenjuei dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT chenweiting dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT hsiehyichung dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT huangchienhao dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT luikarwai dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT hungchenfu dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT wangchingting dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT chaipeimei dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT linchenchun dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT linchunyen dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT linshiming dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization AT sheenishyan dynamicchangeofalbuminbilirubinscoreisgoodpredictiveparameterforprognosisinchronichepatitischepatocellularcarcinomapatientsreceivingtransarterialchemoembolization |